Health Catalyst Capital Management is a venture capital fund investing in high growth US-based Healthcare IT businesses focused in a few key themes, each with potential to achieve $1 billion enterprise value in new or disrupted markets globally.

 

Trend Spotting

Healthcare: Focusing on acyclic market approaching $3 trillion in the USA, with potential cost take-out of $800 billion through applied IT, consumerization, and shift to value-based payments.

Transformational Change

Trend Spotting: Investing early in a few key emerging themes that offer potential to create large enterprises including Personalized Medicine, Patient Navigation, and Hospital Workflow Automation.

Transformation: With financial returns as top priority, investing in digital health businesses that are transforming healthcare with better patient outcomes and lower cost.

Value Creation

Value Creation: Leveraging extensive network built over two decades for deal sourcing, diligence, and company building. Connections include deep bench of industry luminaries and C-suites of Blue Chip healthcare organizations.

 

Exit Options: Validating multiple exit options as an integral part of theme development and before investment. Extensive IPO experience and direct relationships with strategic acquirers and crossover fund investors enhance traditional paths to exit.

 


 

Current Investments

 

PierianDx

ReferWell


 
 

Representative Previous Investments1

 

Remedy Partners

Cavulus

Medtel

Pawaa

Nurep

1 Doc Way

Genmet

Artemis Health

Board Vitals

Represent investments by Mr. Boorady at prior funds or personally within the past three
years which would qualify for the Health Catalyst Capital Strategy.